Oct 9, 2009 | Medical News Today
Triple Therapy Halves Exacerbations In Moderate-to-Severe COPD
Main Category: COPD Also Included In: Respiratory / Asthma Article Date: 08 Oct 2009 - 19:00 PDT Patients with moderate to severe chronic obstructive pulmonary disease can benefit from triple therapy that includes a long-acting I2-agonist , an inhaled corticosteroid and an anti-muscarinic agent, according to researchers in Germany.
Map Pharmaceuticals, Inc. (Mapp) Cfo Christopher y Chai sells 10,000 Shares
CFO of MAP PHARMACEUTICALS, INC. Christopher Y Chai sells 10,000 shares of MAPP on 10/01/2009 at an average price of $10.26 a share.
[Efficacy of nebulized budesonide in severe exacerbation of bronchial asthma]
Sixty-eight patients admitted for a severe attack of BA were examined. The forced expiratory volume per sec was less than 40% and the peak forced expiration rate was less than 150 l/min. First-line therapy included inhaled salbutamol , oxygen, and intravenous prednisolone .
Symbicort(R) Turbuhaler(R) SMART Improves Asthma Symptom Control And...
European Respiratory Society Congress 2009, Vienna, Austria, 15 September 2009: Symbicort Turbuhaler Maintenance and Reliever Therapy provides effective symptom control and reduces the risk of severe exacerbations in symptomatic asthma patients on inhaled corticosteroids or combination therapy of ICS and long-acting beta agonists over six months ...
AstraZeneca to cut 113 Westboro jobs
Pharmaceutical company AstraZeneca Plc will cut 113 jobs at its Westboro plant during the last three months of the year.
AstraZeneca will cut 113 jobs in Massachusetts
Two local employers tied to the health industry are making opposite moves on the job front - one is laying off more than 10 percent of its Massachusetts workforce, while the other wants to rapidly hire a few hundred employees.
New England Journal of Medicine
Drug Therapy: Asthma . Throughout the second row of Table 2 , and in the paragraph beginning with "There are differences," near the end of the section on Inhaled Corticosteroids , the phrase "solution for nebulization" should have read "suspension for nebulization." The article has been corrected at NEJM.org.
DEAR DR. DONOHUE: I started treatment for asthma for the first time at age 80. At first I took prednisone and albuterol.
Main Category: Respiratory / Asthma Also Included In: COPD Article Date: 30 Aug 2009 - 1:00 PDT Contrary to other research findings, patients using the inhaled corticosteroid budesonide to treat Chronic Obstructive Pulmonary Disease are not at increased risk of pneumonia , and the drug is safe to use in these patients, concludes an Article in this ...
Experts Question Study's Asthma Drug Safety Claim
An author of a new industry-funded study on the safety of a commonly prescribed type of inhaled asthma drug says the findings should be "reassuring" to patients who use them.
Budesonide is not beneficial for the treatment of diarrhea in metastatic melanoma patients
Patients with stage III or IV melanoma taking ipilimumab and the oral steroid budesonide to reduce side effects did not have less diarrhea, a known side effect of ipilimumab, according to results of a phase II trial published in Clinical Cancer Research, a journal of the American Association for Cancer Research.
Budesonide is not beneficial for the treatment of diarrhea in metastatic melanoma patients
Patients with stage III or IV melanoma taking ipilimumab and the oral steroid budesonide to reduce side effects did not have less diarrhea, a known side effect of ipilimumab, according to results of a phase II trial published in Clinical Cancer Research, a journal of the American Association for Cancer Research.
Combination formoterol and budesonide as maintenance and reliever...
NEW illiniengineer asthma Abstract BACKGROUND: Traditionally inhaled treatment for asthma has been considered as preventer and reliever therapy.
Combination formoterol and budesonide as maintenance and reliever...
NEW illiniengineer asthma Abstract BACKGROUND: Traditionally inhaled treatment for asthma has been considered as preventer and reliever therapy.
Asthma sufferers in the US will continue to suffer
I have had asthma for over 10 years. At the onset of this horrible disease, I was spending every weekend in the hospital ER receiving steroids via a needle in my butt.
MAP Pharmaceuticals, Inc. Announces Termination of AstraZeneca PLC Pediatric Asthma Collaboration
MAP Pharmaceuticals, Inc. today announced that it has received a notice of termination of the license agreement with AstraZeneca related to the company's Unit Dose Budesonide product candidate.
Verus Pharmaceuticals files lawsuit against AstraZeneca
SAN DIEGO A pharmaceutical company focused on drugs for children has filed a lawsuit against Anglo-Swedish drug maker AstraZeneca.
Verus Pharmaceuticals Announces a Lawsuit Against AstraZeneca AB and Tika Lakemedel AB
Verus Pharmaceuticals, Inc. , a specialty pharmaceutical company, announced today that it has filed a lawsuit against AstraZeneca AB and Tika Lakemedel AB in the Supreme Court of the State of New York, in which it is seeking $1.3 billion on claims of fraud, breach of contract, and conversion.
Budesonide/formoterol Plus Tiotropium Improves The Quality Of Life Of Patients With Severe COPD
Main Category: COPD Also Included In: Respiratory / Asthma Article Date: 27 May 2009 - 5:00 PDT Preliminary results from a double-blind, randomised, multicentre trial among 660 patients with chronic obstructive pulmonary disease show that budesonide/formoterol plus tiotropium significantly improves disease control and patients' quality of life.1,2 ...
SYMBICORT(R) Added To Tiotropium Provided Clinically Significant...
Data presented at this year's American Thoracic Society congress, demonstrated that SYMBICORT added to SpirivaTM provided greater clinical improvements than tiotropium alone over a 12-week treatment period.1,2 Results of the CLIMB study showed that the occurrence of severe exacerbations was reduced by as much as 62 percent in patients where ...
Also on Topix